Neumann-Mufweba A, Kimani S, Khan SF, Chibale K, Prince S. The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity. EXCLI J. [Internet]. 2022 Apr. 4 [cited 2024 Jul. 26];21:656-79. Available from: https://excli.de/excli/article/view/4323